Pentasa (Mesalazin)
Mesalazine sustained-release tablets for the treatment of inflammation in ulcerative colitis.
- WirkeintrittOnsetDélai d’actionWerkingsaanvang
- The effect builds up with regular intake.
- FormFormFormeVorm
- Extended-Release Tablets
So wirkt es:How it works:Mode d’action :Zo werkt het: Mesalazine inhibits inflammatory processes directly in the intestinal mucosa. The extended-release tablets disintegrate into coated granules that release the active ingredient evenly throughout the entire gastrointestinal tract. Mesalazine is used to treat ulcerative colitis during flare-ups and to prevent relapses.
- When ulcerative colitis is confirmed by a specialist
- If you are already taking Pentasa at a fixed dose and tolerating it well
- If current blood, kidney and liver values are available
Anwendung & wichtige HinweiseUse & important informationUtilisation et informations importantesGebruik en belangrijke aandachtspunten
Anwendung:Use:Utilisation :Gebruik: Extended-release tablets for oral administration, usually divided into several doses per day, swallowed whole with plenty of liquid. The daily dose and its division will be determined by the doctor.
Verfügbare Stärken:Available strengths:Dosages disponibles :Beschikbare sterktes: 500 mg · 1000 mg
Do not use if you are allergic to mesalazine or salicylates, or if you have severe liver or kidney disease. Consult a doctor immediately if you experience fever with rash, abdominal cramps with severe headache, unexplained bleeding, chest pain, or frequent bloody diarrhea.

